Affiliation:
1. Department of Pharmaceutical Quality Assurance, Kisan Vidya Prasarak Sanstha’s Institute of Pharmaceutical Education, Boradi 425428.
Abstract
Quality by Design (QbD) has as a new concept for the development of high-quality pharmaceutical products. It is an essential component of the modern approach to pharmaceutical quality. QbD is the best way to build quality into all pharmaceutical products, but it poses a significant challenge to the pharmaceutical industry, whose processes are time-bound, despite inherent process and material variability. Throughout the design and development of a product, it is critical to define the desired product performance profile [Target Product Profile (TPP), Target Product Quality Profile (TPQP)] and identify critical quality attributed to the product (CQA). Applications of QbD to pharmaceutical processes (formulation development) and analytical development are briefly discussed. A standardized pharmaceutical quality system that is applicable throughout the product's lifecycle and emphasizes an integrated approach to risk management and science should be developed, resulting in better quality medicines for patients.ICH documents such as ICH Q8, i.e. Pharmaceutical development; ICH Q9, i.e. Quality Risk Management; ICH Q10, i.e. Pharmaceutical Quality Systems, and FDA's Process Analytical Technology (PAT) were referred to in order to ensure drug product quality. QbD allows formulation and manufacturing variables to be properly understood and controlled.
Reference34 articles.
1. Bhadra RM, Luhar S V, Narkhede SB, Professor A. A brief review on Quality by Design [QbD] a Systematic Approach Future pharmaceutical quality system: Paper Title:-A brief review on Quality by Design [QbD] a Systematic Approach. 2019; 6(6). Available from: www.jidps.com
2. Jayashri J.Bhise Omprakash G. Bhushnre. Journal of drug delivery and therapeutics (jddt). J Drug Deliv Ther. 2019; 9(3):661–8.
3. Q9: Quality Risk Management. ICH Harmonized Tripartite Guidelines. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2006.
4. Q10: Pharmaceutical Quality System, ICH Tripartite Guidelines. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2007.
5. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS J. 2014; 16(4):771–83.